We are developing a pipeline of novel therapies which target cancer patients poorly served by existing treatment options, through collaborations with scientists and partnerships with other organisations.

Kazia Therapeutics is oncology-focused, with a robust in-house pipeline and demonstrated track record of collaborating with institutions, as well as in-licensing and out-licensing IP

If you would like to partner with us contact us at info@kaziatherapeutics.com